Figure 5From: T/L-type calcium channel blocker reduces the composite ranking of relative risk according to new KDIGO guidelines in patients with chronic kidney disease Difference in CKD severity changes between the two treatment groups. (A) Changes in risk scores in the two treatment groups. Numbers in bars indicate the number of patients. (B) Comparison of the proportion with “Risk reduction” and “Risk increase” between the two treatment groups.Back to article page